{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:59:16Z","timestamp":1790773156621,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biofilm"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bioflm.2026.100387","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:40:58Z","timestamp":1785800458000},"page":"100387","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pharmacodynamic modeling of colistin and imipenem against in vitro Pseudomonas aeruginosa biofilms"],"prefix":"10.1016","volume":"12","author":[{"given":"Yuchen","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinqiu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda B.S.","family":"Aulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oana","family":"Ciofu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parth J.","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"H\u00f8iby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengzhuang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingjie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1664-7314","authenticated-orcid":false,"given":"J.G. Coen","family":"van Hasselt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioflm.2026.100387_bib1","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1086\/518136","article-title":"Health care\u2013associated infections: major issues in the early years of the 21st century","volume":"45","author":"Wenzel","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bioflm.2026.100387_bib2","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1513\/AnnalsATS.201603-194FR","article-title":"Microbial biofilms in pulmonary and critical care diseases","volume":"13","author":"Boisvert","year":"2016","journal-title":"Annals ATS"},{"key":"10.1016\/j.bioflm.2026.100387_bib3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/sur.2016.052","article-title":"Effect of the endOclear device on biofilm in endotracheal tubes","volume":"18","author":"Bardes","year":"2017","journal-title":"Surg Infect"},{"key":"10.1016\/j.bioflm.2026.100387_bib4","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1034\/j.1399-3003.2000.16d30.x","article-title":"Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus","volume":"16","author":"D\u00f6ring","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.bioflm.2026.100387_bib5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jcf.2009.04.005","article-title":"Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: a European consensus","volume":"8","author":"Heijerman","year":"2009","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.bioflm.2026.100387_bib6","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nrd4000","article-title":"Applying insights from biofilm biology to drug development \u2014 can a new approach be developed?","volume":"12","author":"Bjarnsholt","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bioflm.2026.100387_bib7","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-015-1832-x","article-title":"Structure-based prediction of anti-infective drug concentrations in the human lung epithelial lining fluid","author":"V\u00e4litalo","year":"2016","journal-title":"Pharm Res"},{"key":"10.1016\/j.bioflm.2026.100387_bib8","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-017-2336-7","article-title":"Validation of a model predicting anti-infective lung penetration in the epithelial lining fluid of humans","volume":"35","author":"Aulin","year":"2018","journal-title":"Pharm Res"},{"key":"10.1016\/j.bioflm.2026.100387_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00239-019-09914-3","article-title":"Antimicrobial resistance in bacteria: mechanisms, evolution, and persistence","volume":"88","author":"Christaki","year":"2020","journal-title":"J Mol Evol"},{"key":"10.1016\/j.bioflm.2026.100387_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.770518","article-title":"Limitations of antibiotic MIC-based PK-PD metrics: looking back to move forward","volume":"12","author":"Landersdorfer","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bioflm.2026.100387_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/jac\/dkaa450","article-title":"Distinct evolution of colistin resistance associated with experimental resistance evolution models in Klebsiella pneumoniae","author":"Aulin","year":"2021","journal-title":"The Journal of antimicrobial chemotherapy"},{"key":"10.1016\/j.bioflm.2026.100387_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/cpt.2194","article-title":"Biomarker\u2010guided individualization of antibiotic therapy","author":"Aulin","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bioflm.2026.100387_bib13","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1124\/pr.111.005769","article-title":"Pharmacokinetic-pharmacodynamic modeling of antibacterial drugs","volume":"65","author":"Nielsen","year":"2013","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.bioflm.2026.100387_bib14","article-title":"Semi-mechanistic modeling of resistance development to \u03b2-lactam and \u03b2-lactamase-inhibitor combinations","author":"Tandar","year":"2023","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.bioflm.2026.100387_bib15","article-title":"Population pharmacokinetics of unbound and total teicoplanin in critically ill pediatric patients","author":"Aulin","year":"2020","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bioflm.2026.100387_bib16","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/bcp.13016","article-title":"Evaluating renal function and age as predictors of amikacin clearance in neonates: model-based analysis and optimal dosing strategies","volume":"82","author":"Illamola","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bioflm.2026.100387_bib17","series-title":"Guideline on the use of pharmacokinetics and pharmacodynamics in the development of antibacterial medicinal products","year":"2016"},{"key":"10.1016\/j.bioflm.2026.100387_bib18","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1128\/AAC.00126-11","article-title":"Pharmacokinetics\/pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa biofilms","volume":"55","author":"Hengzhuang","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2026.100387_bib19","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1128\/AAC.01393-12","article-title":"High \u03b2-lactamase levels change the pharmacodynamics of \u03b2-lactam antibiotics in Pseudomonas aeruginosa biofilms","volume":"57","author":"Hengzhuang","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2026.100387_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00857-17","article-title":"Colistin is extensively lost during standard in vitro experimental conditions","author":"Karvanen","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2026.100387_bib21","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1128\/AAC.29.5.936","article-title":"Degradation kinetics of imipenem in normal saline and in human serum","volume":"29","author":"Swanson","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2026.100387_bib22","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1128\/AAC.40.4.904","article-title":"Comparative in vitro pharmacodynamics of imipenem and meropenem against Pseudomonas aeruginosa","volume":"40","author":"White","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2026.100387_bib23","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1208\/s12248-009-9112-5","article-title":"Handling data below the limit of quantification in mixed effect models","volume":"11","author":"Bergstrand","year":"2009","journal-title":"AAPS J"},{"key":"10.1016\/j.bioflm.2026.100387_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2013.00263","article-title":"The role of bystander effects in the antitumor activity of the hypoxia-activated prodrug PR-104","author":"Foehrenbacher","year":"2013","journal-title":"Front Oncol"},{"key":"10.1016\/j.bioflm.2026.100387_bib25","doi-asserted-by":"crossref","first-page":"7331","DOI":"10.1128\/AAC.03510-14","article-title":"Comparison of intrapulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and colistin after aerosol delivery and intravenous administration of CMS in critically ill patients","volume":"58","author":"Matthieu","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2026.100387_bib26","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/bcp.12901","article-title":"Pooled population pharmacokinetic model of imipenem in plasma and the lung epithelial lining fluid","volume":"81","author":"van Hasselt","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bioflm.2026.100387_bib28","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/cpt.3099","article-title":"Virtual patient simulation using copula modeling","volume":"115","author":"Zwep","year":"2024","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bioflm.2026.100387_bib29","article-title":"Generation of realistic virtual adult populations using a model-based copula approach","author":"Guo","year":"2024","journal-title":"medRxiv"},{"key":"10.1016\/j.bioflm.2026.100387_bib30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1128\/AAC.00133-06","article-title":"Interpretation of antibiotic concentration ratios measured in epithelial lining fluid","volume":"52","author":"Kiem","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2026.100387_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02025-16","article-title":"Pharmacokinetics\/Pharmacodynamics of pulmonary delivery of colistin against Pseudomonas aeruginosa in a mouse lung infection model","volume":"61","author":"Lin","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2026.100387_bib32","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1128\/AAC.00182-11","article-title":"Pharmacokinetic\/Pharmacodynamic (PK\/PD) indices of antibiotics predicted by a semimechanistic PKPD model: a step toward model-based dose optimization","volume":"55","author":"Nielsen","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2026.100387_bib33","series-title":"Model evaluation of continuous data pharmacometric models: metrics and graphics","author":"Nguyen","year":"2016"},{"key":"10.1016\/j.bioflm.2026.100387_bib34","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.00113-17","article-title":"Pseudomonas aeruginosa aggregate Formation in an alginate bead model System exhibits in vivo-like characteristics","volume":"83","author":"S\u00f8nderholm","year":"2017","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.bioflm.2026.100387_bib35","article-title":"Diffusion retardation by binding of tobramycin in an alginate biofilm model","author":"Cao","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bioflm.2026.100387_bib36","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1093\/jac\/dkv058","article-title":"Antibiotic penetration and bacterial killing in a Pseudomonas aeruginosa biofilm model","volume":"70","author":"Cao","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bioflm.2026.100387_bib37","doi-asserted-by":"crossref","first-page":"8671","DOI":"10.3390\/ijms21228671","article-title":"Pseudomonas aeruginosa biofilms","volume":"21","author":"Thi","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bioflm.2026.100387_bib38","doi-asserted-by":"crossref","first-page":"6746","DOI":"10.1128\/JB.183.23.6746-6751.2001","article-title":"Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials","volume":"183","author":"Spoering","year":"2001","journal-title":"J Bacteriol"},{"key":"10.1016\/j.bioflm.2026.100387_bib39","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/s41579-022-00682-4","article-title":"Tolerance and resistance of microbial biofilms","volume":"20","author":"Ciofu","year":"2022","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.bioflm.2026.100387_bib40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejpb.2019.08.006","article-title":"In vitro evaluation of Pseudomonas aeruginosa chronic lung infection models: are agar and calcium-alginate beads interchangeable?","volume":"143","author":"Torres","year":"2019","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.bioflm.2026.100387_bib41","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1128\/AAC.35.5.1008","article-title":"Induction of beta-lactamase production in Pseudomonas aeruginosa biofilm","volume":"35","author":"Giwercman","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2026.100387_bib42","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1128\/AAC.48.4.1168-1174.2004","article-title":"Dynamics and spatial distribution of \u03b2-Lactamase expression in Pseudomonas aeruginosa biofilms","volume":"48","author":"Bagge","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2026.100387_bib43","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.3389\/fmicb.2020.02057","article-title":"Tolerance and persistence of Pseudomonas aeruginosa in biofilms exposed to antibiotics: molecular mechanisms, antibiotic strategies and therapeutic perspectives","volume":"11","author":"Soares","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bioflm.2026.100387_bib44","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1046\/j.1365-2958.2003.03673.x","article-title":"Cationic antimicrobial peptides activate a two-component regulatory system, PmrA-PmrB, that regulates resistance to polymyxin B and cationic antimicrobial peptides in Pseudomonas aeruginosa","volume":"50","author":"McPhee","year":"2003","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.bioflm.2026.100387_bib45","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2958.2008.06152.x","article-title":"Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB\u2010oprM genes","volume":"68","author":"Pamp","year":"2008","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.bioflm.2026.100387_bib46","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1574-695X.2012.00929.x","article-title":"The metabolically active subpopulation in Pseudomonas aeruginosa biofilms survives exposure to membrane-targeting antimicrobials via distinct molecular mechanisms","volume":"65","author":"Chiang","year":"2012","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.bioflm.2026.100387_bib47","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/jac\/dkz133","article-title":"Potentiation of imipenem by relebactam for Pseudomonas aeruginosa from bacteraemia and respiratory infections","volume":"74","author":"Horner","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bioflm.2026.100387_bib48","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1128\/AAC.48.4.1175-1187.2004","article-title":"Pseudomonas aeruginosa biofilms exposed to Imipenem exhibit changes in global gene expression and \u03b2-Lactamase and alginate production","volume":"48","author":"Bagge","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2026.100387_bib49","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/clinids\/10.4.892","article-title":"Resistance to Imipenem in Pseudomonas aeruginosa: clinical experience and biochemical mechanisms","volume":"10","author":"Quinn","year":"1988","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.bioflm.2026.100387_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2024.107180","article-title":"Effects of lung inflammation and injury on pulmonary tissue penetration of meropenem and vancomycin in a model of unilateral lung injury","volume":"64","author":"Geilen","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bioflm.2026.100387_bib51","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.2147\/COPD.S209513","article-title":"Nebulized colistin and continuous cyclic Azithromycin in severe COPD patients with chronic bronchial infection due to Pseudomonas aeruginosa: a retrospective cohort Study","volume":"14","author":"Mont\u00f3n","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.bioflm.2026.100387_bib52","article-title":"The efficacy and safety of intravenous colistin plus aerosolized colistin versus intravenous colistin alone in critically ill trauma patients with multi-drug resistant gram-negative Bacilli infection","volume":"15","author":"Maan","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.bioflm.2026.100387_bib53","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1128\/AAC.06486-11","article-title":"In vivo pharmacokinetics\/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection","volume":"56","author":"Hengzhuang","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2026.100387_bib54","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02074-19","article-title":"Impact of daptomycin dose exposure alone or in combination with \u03b2-lactams or rifampin against vancomycin-resistant enterococci in an in Vitro biofilm model","author":"Jahanbakhsh","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2026.100387_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106246","article-title":"In vitro pharmacokinetics\/pharmacodynamics of continuous ceftazidime infusion alone and in combination with colistin against Pseudomonas aeruginosa biofilm","volume":"57","author":"G\u00f3mez-Junyent","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bioflm.2026.100387_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioflm.2024.100224","article-title":"Synergistic combinations of novel polymyxins and rifampicin with improved eradication of colistin-resistant Pseudomonas aeruginosa biofilms","volume":"8","author":"J\u00f8rgensen","year":"2024","journal-title":"Biofilm"},{"key":"10.1016\/j.bioflm.2026.100387_bib57","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1093\/jac\/dkx269","article-title":"Can a pharmacokinetic\/pharmacodynamic (PKPD) model be predictive across bacterial densities and strains? External evaluation of a PKPD model describing longitudinal in vitro data","volume":"72","author":"Nielsen","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bioflm.2026.100387_bib58","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1021\/acs.molpharmaceut.9b00968","article-title":"Model-Informed drug development in pulmonary delivery: semimechanistic pharmacokinetic\u2013pharmacodynamic modeling for evaluation of treatments against chronic Pseudomonas aeruginosa lung infections","volume":"17","author":"Sou","year":"2020","journal-title":"Mol Pharmaceutics"},{"key":"10.1016\/j.bioflm.2026.100387_bib59","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.3390\/biomedicines11082316","article-title":"Pharmacodynamic model of the dynamic response of Pseudomonas aeruginosa biofilms to antibacterial treatments","volume":"11","author":"Roychowdhury","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.bioflm.2026.100387_bib60","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s11538-012-9796-z","article-title":"Effect of periodic disinfection on persisters in a one-dimensional biofilm model","volume":"75","author":"Cogan","year":"2013","journal-title":"Bull Math Biol"}],"container-title":["Biofilm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590207526000444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590207526000444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:21:38Z","timestamp":1790770898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590207526000444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":59,"alternative-id":["S2590207526000444"],"URL":"https:\/\/doi.org\/10.1016\/j.bioflm.2026.100387","relation":{},"ISSN":["2590-2075"],"issn-type":[{"value":"2590-2075","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacodynamic modeling of colistin and imipenem against in vitro Pseudomonas aeruginosa biofilms","name":"articletitle","label":"Article Title"},{"value":"Biofilm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioflm.2026.100387","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100387"}}